Pharmaceutical Commerce
Go in-between the pages and behind the scenes of Pharmaceutical Commerce Magazine
Episodes
In this week’s Pharma Pulse, the launch of the Ember Cube 2, exclusive policy insights from Asembia AXS26, a record-breaking prescription spending outlook for 2026 and more.
In this week’s Pharma Pulse, GEODIS’ cold chain expansion in the Midwest, a potential multi-billion dollar shift in cell therapy, and the White House’s new push for psychedelic mental health treatments.
In today’s Pharma Pulse, Walgreens reshapes pharmacist roles, pharmacies expand injectable access, GoodRx and Eli Lilly broaden Zepbound access, radiopharma investment grows, and AbbVie signs a $745 million Haisco licensing deal.
In this week’s Pharma Pulse, tariffs reshape drug supply, a fragile ceasefire tests global pharma, Wegovy goes higher-dose, and patients still can't get appointments fast enough.
In today’s Pharma Pulse, Shionogi acquires global rights to the ALS treatment Radicava, and experts monitor drug supply chains as the U.S.-Iran conflict drives up logistics costs.
In Pharma Pulse, Foundayo’s record 50-day FDA approval and the threat of pharmacy data consolidation to independent pharmacies.
In today’s Pharma Pulse, Cold Chain Technologies sets a formal 2050 Net Zero goal to tackle the industry’s Scope 3 emissions, while a new Op/Ed highlights operational discipline as the vital driver for sustaining U.S. generic drug supplies.
In today's Pharma Pulse, the FDA flags misleading promotional claims from ImmunityBio regarding its cancer therapy and MedImpact launches new solutions to address the skyrocketing employer costs of GLP-1 weight management therapies.
while a new report explores the economic pressures and chronic shortages destabilizing the U.S.
generics market
In today's Pharma Pulse, the FDA approves Icotyde as the first targeted oral
peptide therapy for moderate-to-severe plaque psoriasis, while Cold Chain Technologies prepares to debut its MedAssure orchestration platform at LogiPharma 2026
In today’s Pharma Pulse, Eli Lilly issues a safety warning, and SteinCares enters a licensing agreement with Shilpa Biologicals to expand biosimilar access in Latin America.
In today’s Pharma Pulse, the FDA approved Wellcovorin as the first therapy for an
ultra-rare neurological disorder, and disparities in OTC naloxone access persist despite declining retail prices.
arthritis.
Popular Podcasts
Ding dong! Join your culture consultants, Matt Rogers and Bowen Yang, on an unforgettable journey into the beating heart of CULTURE. Alongside sizzling special guests, they GET INTO the hottest pop-culture moments of the day and the formative cultural experiences that turned them into Culturistas. Produced by the Big Money Players Network and iHeartRadio.
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
The World's Most Dangerous Morning Show, The Breakfast Club, With DJ Envy, Jess Hilarious, And Charlamagne Tha God!
Nancy Grace dives deep into the day’s most shocking crimes and asks the tough questions in her new daily podcast – Crime Stories with Nancy Grace. Nancy Grace had a perfect conviction record during her decade as a prosecutor and used her TV show to find missing people, fugitives on the run and unseen clues. Now, she will use the power of her huge social media following and the immediacy of the internet to deliver daily bombshells! Theme Music: Audio Network